Thermo Fisher Scientific Inc (TMO)
573.00
+1.27
(+0.22%)
USD |
NYSE |
Apr 26, 12:08
Thermo Fisher Scientific Market Cap: 218.49B for April 26, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 25, 2024 | 218.01B |
| April 24, 2024 | 220.17B |
| April 23, 2024 | 219.10B |
| April 22, 2024 | 209.10B |
| April 19, 2024 | 207.73B |
| April 18, 2024 | 206.49B |
| April 17, 2024 | 208.67B |
| April 16, 2024 | 211.46B |
| April 15, 2024 | 212.72B |
| April 12, 2024 | 215.53B |
| April 11, 2024 | 219.09B |
| April 10, 2024 | 218.76B |
| April 09, 2024 | 224.67B |
| April 08, 2024 | 220.70B |
| April 05, 2024 | 220.96B |
| April 04, 2024 | 217.58B |
| April 03, 2024 | 219.64B |
| April 02, 2024 | 217.94B |
| April 01, 2024 | 220.19B |
| March 28, 2024 | 221.62B |
| March 27, 2024 | 220.92B |
| March 26, 2024 | 216.90B |
| March 25, 2024 | 218.71B |
| March 22, 2024 | 222.34B |
| March 21, 2024 | 222.74B |
| Date | Value |
|---|---|
| March 20, 2024 | 221.18B |
| March 19, 2024 | 222.20B |
| March 18, 2024 | 221.18B |
| March 15, 2024 | 222.74B |
| March 14, 2024 | 223.03B |
| March 13, 2024 | 226.24B |
| March 12, 2024 | 227.74B |
| March 11, 2024 | 228.57B |
| March 08, 2024 | 227.88B |
| March 07, 2024 | 227.90B |
| March 06, 2024 | 225.55B |
| March 05, 2024 | 222.92B |
| March 04, 2024 | 221.79B |
| March 01, 2024 | 219.76B |
| February 29, 2024 | 217.42B |
| February 28, 2024 | 218.12B |
| February 27, 2024 | 215.89B |
| February 26, 2024 | 214.86B |
| February 23, 2024 | 215.33B |
| February 22, 2024 | 213.72B |
| February 21, 2024 | 210.81B |
| February 20, 2024 | 209.01B |
| February 16, 2024 | 208.90B |
| February 15, 2024 | 209.18B |
| February 14, 2024 | 209.06B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
101.82B
Minimum
Mar 23 2020
263.18B
Maximum
Dec 31 2021
186.05B
Average
199.53B
Median
Market Cap Benchmarks
| Fonar Corp | 107.49M |
| XWELL Inc | 7.739M |
| ProPhase Labs Inc | 86.98M |
| Applied DNA Sciences Inc | 3.944M |
| Veracyte Inc | 1.469B |
Market Cap Related Metrics
| PE Ratio | 37.09 |
| PS Ratio | 5.188 |
| Price to Book Value | 4.675 |
| Price to Free Cash Flow | 32.10 |
| Price | 573.00 |
| Earnings Yield | 2.70% |
| Operating PE Ratio | 30.38 |
| Normalized PE Ratio | 34.55 |